Tiny radioactive tracer reveals drug absorption in healthy men
NCT ID NCT03783000
First seen Apr 15, 2026 · Last updated May 28, 2026 · Updated 7 times
Summary
This early-stage study in 6 healthy male volunteers measured how much of the experimental drug BI 425809 enters the bloodstream after being taken as a pill compared to a tiny radioactive dose given directly into a vein. The goal was to understand the drug's oral bioavailability — how well the body absorbs it. No treatment was given for any disease, and the results help guide future dosing for conditions like Alzheimer's or schizophrenia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.